Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ubenimex

EU orphan designation number: EU/3/16/1638   
Active ingredient: Ubenimex
Indication: Treatment of pulmonary arterial hypertension
Sponsor: Eiger Biopharmaceuticals Europe Limited
30 Upper High Street, Thame, Oxon, OX9 3EZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/03/2016 Orphan designation EMA/OD/179/15 (2016)1876 of 21/03/2016